Kuehn Law is investigating whether TG Therapeutics (TGTX) officers and directors breached fiduciary duties, with allegations centered on potential self-dealing. The news is negative for governance/overhang risk, though no financial impact or claims amount were provided.
Kuehn Law is investigating whether TG Therapeutics (TGTX) officers and directors breached fiduciary duties, with allegations centered on potential self-dealing. The news is negative for governance/overhang risk, though no financial impact or claims amount were provided.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
